Literature DB >> 30280791

IgG cryoglobulinemia.

F Gulli1, U Basile, L Gragnani, C Napodano, K Pocino, L Miele, S A Santini, A L Zignego, A Gasbarrini, G L Rapaccini.   

Abstract

OBJECTIVE: Mixed Cryoglobulinemia is the most well-known Hepatitis C Virus (HCV)-associated extrahepatic manifestation. MC is both an autoimmune and B-lymphoproliferative disorder. Cryoglobulins (CGs) are classified into three groups according to immunoglobulin (Ig) composition: type I is composed of one isotype or Ig class. Type II and type III mixed CGs are immune complexes composed of polyclonal IgGs acting as autoantigens and mono, polyclonal or oligoclonal IgM with rheumatoid factor activity. IgG1 and IgG3 are the predominant subclasses involved. This study shows the simultaneous presence of IgG-RF and IgG3, supporting the hypothesis of an involvement of this subclass in the initiation of early stages of CGs. PATIENTS AND METHODS: We describe a case series of six HCV-positive patients, all of whom had peripheral neuropathy and transient ischemic attacks, presenting cryoprecipitates formed by IgG3 and IgG1. Cryoprecipitate IgG subclass research was carried out by immunofixation electrophoresis by using antisera against IgG1, IgG2, IgG3, and IgG4.
RESULTS: Our six patients presented with an immunochemical pattern characterized by the mere presence of IgG1 and IgG3 subclasses with probable RF activity and one of these six patients exhibited monoclonal IgG3 in his cerebrospinal fluid.
CONCLUSIONS: We can hypothesize that the IgG passage through the blood-brain barrier could have contributed to the cause of TIAs, through a mechanism involving the precipitation of circulating immune complexes formed by the two subclasses in the intrathecal vessels.

Entities:  

Year:  2018        PMID: 30280791     DOI: 10.26355/eurrev_201809_15943

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

Review 1.  Hepatitis Virus C-associated Nephropathy: A Review and Update.

Authors:  Elmukhtar Habas; Khalifa L Farfar; Nada Errayes; Ala M Habas; Mehdi Errayes; Gamal Alfitori; Amnna Rayani; Mohamed Elgara; Aisha H Al Adab; Abdulnaser Elzouki
Journal:  Cureus       Date:  2022-07-27

2.  A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.

Authors:  Loreta A Kondili; Monica Monti; Maria Giovanna Quaranta; Laura Gragnani; Valentina Panetta; Giuseppina Brancaccio; Cesare Mazzaro; Marcello Persico; Mario Masarone; Ivan Gentile; Pietro Andreone; Salvatore Madonia; Elisa Biliotti; Roberto Filomia; Massimo Puoti; Anna Ludovica Fracanzani; Diletta Laccabue; Donatella Ieluzzi; Carmine Coppola; Maria Grazia Rumi; Antonio Benedetti; Gabriella Verucchi; Barbara Coco; Liliana Chemello; Andrea Iannone; Alessia Ciancio; Francesco Paolo Russo; Francesco Barbaro; Filomena Morisco; Luchino Chessa; Marco Massari; Pierluigi Blanc; Anna Linda Zignego
Journal:  Hepatology       Date:  2022-01-19       Impact factor: 17.298

3.  IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway.

Authors:  Xinyu Li; Wen Chen; Jing Jia; Chunkang Yang; Yisen Huang; Rongyu Xu; Shen Guan; Ruijun Ma; Haitao Yang; Lifeng Xie
Journal:  Cancer Cell Int       Date:  2021-07-27       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.